Publications by authors named "Satomi Hashimoto"

Claim this Profile
G
Genes encoding lipid II flippase MurJ and peptidoglycan hydrolases are required for chloroplast division in the moss Physcomitrella patens.
Hanae Utsunomiya, Nozomi Saiki, Hayato Kadoguchi, Masaya Fukudome, Satomi Hashimoto

Plant Mol Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Cyclooxygenase-2 1195 G-Carrier Genotype Associated with Intestinal Metaplasia and Endoscopic Findings Based on Kyoto Classification.
Yasuhiro Kodaka, Seiji Futagami, Atsushi Tatsuguchi, Hiroshi Yamawaki, Hitomi Sato, Satomi Hashimoto

Digestion· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep Disturbances in Functional Gastrointestinal Disorders.
Seiji Futagami, Hiroshi Yamawaki, Satomi Hashimoto, Katsuhiko Iwakiri

Intern Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography.
Satomi Hashimoto, Seiji Futagami, Hiroshi Yamawaki, Keiko Kaneko, Yasuhiro Kodaka

J Clin Biochem Nutr· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New horizon of the pathophysiology of functional dyspepsia].
Seiji Futagami, Hiroshi Yamawaki, Satomi Hashimoto, Katsuhiko Iwakiri

Nihon Shokakibyo Gakkai Zasshi· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.
Masaji Okada, Yoko Kita, Satomi Hashimoto, Hitoshi Nakatani, Shiho Nishimastu

Hum Vaccin Immunother· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load.
Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Chisa Kondo, Norio Itokawa, Satomi Hashimoto

Hepatol Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between HCV dynamics and sustained virological responses in chronic hepatitis C genotype 1b patients treated with telaprevir-based triple therapy.
Ai Nakagawa, Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hiroshi Abe, Satomi Hashimoto

Eur J Gastroenterol Hepatol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological characteristics of the regression of corpora lutea in wistar hannover rats: the comparisons with sprague-dawley rats.
Junko Sato, Satomi Hashimoto, Takuya Doi, Naoaki Yamada, Minoru Tsuchitani

J Toxicol Pathol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.
Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Chisa Kondo, Norio Itokawa, Satomi Hashimoto

Hepat Mon· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corneal mineralization in wistar hannover rats.
Satomi Hashimoto, Takuya Doi, Yumi Wako, Junko Sato, Sou Wada

J Toxicol Pathol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial pleuritis with thickened mesothelial hyperplasia in a young beagle dog.
Naoaki Yamada, Satomi Hashimoto, Yuki Tomonari, Hiroko Kokoshima, Takuya Doi

J Toxicol Pathol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.
Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Satomi Hashimoto

J Gastroenterol Hepatol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
Masaji Okada, Yoko Kita, Toshihiro Nakajima, Satomi Hashimoto, Hitoshi Nakatani

Hum Vaccin Immunother· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
Yoko Kita, Satomi Hashimoto, Toshihiro Nakajima, Hitoshi Nakatani, Shiho Nishimatsu

Hum Vaccin Immunother· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b.
Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Norio Itokawa, Yoshiyuki Narahara, Satomi Hashimoto

J Gastroenterol Hepatol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
Yoko Kita, Masaji Okada, Toshihiro Nakajima, Noriko Kanamaru, Satomi Hashimoto

Hum Vaccin· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
Masaji Okada, Yoko Kita, Toshihiro Nakajima, Noriko Kanamaru, Satomi Hashimoto

Hum Vaccin· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than anti-TNF-α antibody in mice.
Masaji Okada, Yoko Kita, Noriko Kanamaru, Satomi Hashimoto, Yasushi Uchiyama

Clin Dev Immunol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel prophylactic vaccine using a prime-boost method and hemagglutinating virus of Japan-envelope against tuberculosis.
Masaji Okada, Yoko Kita, Toshihiro Nakajima, Noriko Kanamaru, Satomi Hashimoto

Clin Dev Immunol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant Mesothelioma in the Thoracic Cavity of a Crj:CD(SD) Rat Characterized by Round Hyalinous Stroma.
Takuya Doi, Yuri Kotani, Kazuaki Takahashi, Satomi Hashimoto, Naoaki Yamada

J Toxicol Pathol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel prophylactic and therapeutic vaccine against tuberculosis.
Masaji Okada, Yoko Kita, Toshihiro Nakajima, Noriko Kanamaru, Satomi Hashimoto

Vaccine· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
Masaji Okada, Yoko Kita, Toshihiro Nakajima, Noriko Kanamaru, Satomi Hashimoto

Vaccine· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models.
Masaji Okada, Yoshinobu Okuno, Satomi Hashimoto, Yoko Kita, Noriko Kanamaru

Vaccine· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models.
Masaji Okada, Yuji Takemoto, Yoshinobu Okuno, Satomi Hashimoto, Yukari Fukunaga

Adv Exp Med Biol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis